Format

Send to

Choose Destination
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13046-50. doi: 10.1073/pnas.1002396107. Epub 2010 Jun 28.

Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis.

Author information

1
Department of Cellular Microbiology, Max Planck Institute for Infection Biology, 10117 Berlin, Germany.

Abstract

ALS is a fatal motor neuron disease of adult onset. Neuroinflammation contributes to ALS disease progression; however, the inflammatory trigger remains unclear. We report that ALS-linked mutant superoxide dismutase 1 (SOD1) activates caspase-1 and IL-1beta in microglia. Cytoplasmic accumulation of mutant SOD1 was sensed by an ASC containing inflammasome and antagonized by autophagy, limiting caspase-1-mediated inflammation. Notably, mutant SOD1 induced IL-1beta correlated with amyloid-like misfolding and was independent of dismutase activity. Deficiency in caspase-1 or IL-1beta or treatment with recombinant IL-1 receptor antagonist (IL-1RA) extended the lifespan of G93A-SOD1 transgenic mice and attenuated inflammatory pathology. These findings identify microglial IL-1beta as a causative event of neuroinflammation and suggest IL-1 as a potential therapeutic target in ALS.

Comment in

PMID:
20616033
PMCID:
PMC2919927
DOI:
10.1073/pnas.1002396107
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center